Last reviewed · How we verify
Curcuminoid
At a glance
| Generic name | Curcuminoid |
|---|---|
| Sponsor | Bangkok Metropolitan Administration Medical College and Vajira Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Curcumin, Vitamin D and Green Tea in IBS-D (NA)
- Curcumin in Critically Ill Patients With Sepsis (NA)
- Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers (PHASE2)
- Supplementation With Sirtuin Activators in Women With Increased Body Weight (NA)
- Curcumin in Combination With 5FU for Colon Cancer (EARLY_PHASE1)
- Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome (NA)
- Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI (NA)
- A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Curcuminoid CI brief — competitive landscape report
- Curcuminoid updates RSS · CI watch RSS
- Bangkok Metropolitan Administration Medical College and Vajira Hospital portfolio CI